Stay updated on Delgocitinib Cream Dose-ranging Clinical Trial

Sign up to get notified when there's something new on the Delgocitinib Cream Dose-ranging Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Delgocitinib Cream Dose-ranging Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record for the delgocitinib atopic dermatitis trial is now displayed, including its design, eligibility criteria, study locations, outcome measures, and record history.
    Difference
    62%
    Check dated 2026-11-08T15:08:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:16:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces an NIH transition notice about using “Super Intelligence” alongside “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T15:17:27.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T20:59:55.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The error page footer now lists site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T21:49:20.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the usual study details with an error page. The screen shows a standard site header and a 403 message, indicating restricted access to the content.
    Difference
    18%
    Check dated 2026-09-20T20:40:32.000Z thumbnail image

Stay in the know with updates to Delgocitinib Cream Dose-ranging Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Delgocitinib Cream Dose-ranging Clinical Trial page.